When are medical apps medical? Off-label use and the Food and Drug Administration
- PMID: 29942563
- PMCID: PMC6001240
- DOI: 10.1177/2055207616662782
When are medical apps medical? Off-label use and the Food and Drug Administration
Abstract
People have a love/hate relationship with rapidly changing healthcare technology. While consumer demand for medical apps continues to grow as rapidly as does supply (there are over 100,000 health, wellness and medical applications, or 'apps' on the market), healthcare professionals and safety experts worry about the impact of these apps on the health consumer. In response to the rapidly growing mobile healthcare sector, the Food and Drug Administration has put forth guidelines to regulate 'mobile medical apps' (MMAs), those health-related apps that are (self) designated as medical devices. In this article, I argue that this decision, to only regulate apps that bill themselves as medical devices, will create a market for 'off-label' app use. Further, I will talk about the oft used analogy between off-label apps and off-label pharmaceuticals, showing that off-labeling apps will provide patients none of the benefits that come with a physician prescribing a drug off-label, while exposing the mobile healthcare consumer to significant risks that go significantly beyond those that we know of (and must accept) from prescription drugs. Recognizing that the Food and Drug Administration is not going to be able to significantly change its policies on oversight, I will suggest specific actions to at least mitigate some of the risks associated with off-label app use.
Keywords: Food and Drug Administration; Medical apps; conflict of interest; mobile healthcare; off-label.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- Aitken M and Gauntlett C. Patient apps for improved healthcare: From novelty to mainstream. Report by the IMS Institute for Healthcare Informatics. 2013. Of these, searched for under either “Healthcare and Fitness” or “Medical”, the IMS study found 23,682 that were genuinely related to healthcare. Of these, 2/3 were oriented to the health consumer (as opposed to the health industry). Of these, an even smaller number would be subject to regulation, according to the guidelines set by the FDA in 2014.
-
- See Agboola, SA, Bates DW and Kvedar JC. Digital Health and Patient Safety. JAMA 2016: 315(16): 1697–1698 and Buijink AW, Visser BJ and Marshall L. Medical apps for smartphones: lack of evidence undermines quality and safety. Evid-Based Med 2013; 13: 90–92. - PubMed
-
- Lupton D. Apps as artefacts: Towards a critical perspective on mobile health and medical apps. In: Lupton D (ed.) Beyond Techno-Utopia: Critical Approaches to Digital Health Technologies. 2014, pp. 134–151. https://www.researchgate.net/publication/280627130_Beyond_Techno-Utopia_... (accessed 10 January 2016).
-
- Rich E and Miah A. Understanding digital health as public pedagogy: A critical framework. In: Lupton D (ed.) Beyond Techno-Utopia: Critical Approaches to Digital Health Technologies. 2014, p. 30. https://www.researchgate.net/publication/280627130_Beyond_Techno-Utopia_... (accessed 10 January 2016).
-
- Krieger W. Medical apps: Public and academic perspectives. Perspect Biol Med 2013; 56: 259–273. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources